Cite
Screening of a composite collection of clinically used drugs and well-annotated compounds for the inhibition of cystathionine-β-synthetase activity
MLA
Mark R. Hellmich, et al. “Screening of a Composite Collection of Clinically Used Drugs and Well-Annotated Compounds for the Inhibition of Cystathionine-β-Synthetase Activity.” Nitric Oxide, vol. 47, May 2015, p. S45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ff1f5a1b370b532e1165a29d0ec29bb6&authtype=sso&custid=ns315887.
APA
Mark R. Hellmich, Antonia Asimakopoulou, Bartosz Szczesny, Andreas Papapetropoulos, Petra Szoleczky, Csaba Szabó, Nadiya Druzhyna, Domokos Gero, & Ciro Coletta. (2015). Screening of a composite collection of clinically used drugs and well-annotated compounds for the inhibition of cystathionine-β-synthetase activity. Nitric Oxide, 47, S45.
Chicago
Mark R. Hellmich, Antonia Asimakopoulou, Bartosz Szczesny, Andreas Papapetropoulos, Petra Szoleczky, Csaba Szabó, Nadiya Druzhyna, Domokos Gero, and Ciro Coletta. 2015. “Screening of a Composite Collection of Clinically Used Drugs and Well-Annotated Compounds for the Inhibition of Cystathionine-β-Synthetase Activity.” Nitric Oxide 47 (May): S45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ff1f5a1b370b532e1165a29d0ec29bb6&authtype=sso&custid=ns315887.